Ezharmia

Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer
BioSpace
Mon, 09/26/22 - 11:32 pm
Daiichi Sankyo
Japan
Ezharmia
relapsed or refractory adult T-cell leukemia/lymphoma